Narrowband UVB Phototherapy

What Is Narrowband UVB?

Narrowband UVB (nbUVB) is a form of ultraviolet B light therapy that emits a precisely defined band of wavelengths centered at 311–313 nanometers. This specific range has been identified as the most therapeutically active portion of the UVB spectrum — the wavelength most effective at suppressing skin inflammation — while excluding the shorter, more damaging wavelengths that cause burning without therapeutic benefit.

Compared to older broadband UVB phototherapy, narrowband UVB achieves superior efficacy at lower cumulative doses and with better tolerability. It has largely replaced broadband UVB and is now considered the first-line phototherapy option for most patients.

Dermatology of Seattle offers narrowband UVB in an on-site, full-body phototherapy booth — a standing enclosure lined with specialized fluorescent bulbs that delivers uniform light exposure to the entire body surface in a single session.

How It Works: The Mechanism

The therapeutic effects of narrowband UVB are rooted in its interaction with immune cells and keratinocytes (skin cells) in the outer layers of the skin:

• T-cell suppression — UVB light induces apoptosis (cell death) in activated CD4+ and CD8+ T-lymphocytes in the skin, reducing the immune attack on normal tissue in psoriasis, eczema, and CTCL
• Cytokine modulation — nbUVB reduces the production of inflammatory cytokines including IL-2, IL-17, IL-23, and TNF-alpha while upregulating anti-inflammatory IL-10
• Keratinocyte normalization — in psoriasis, UVB slows the abnormally rapid cell turnover (the cell cycle is compressed from 28 days to 3-4 days in psoriasis; UVB restores normal kinetics)
• Melanocyte stimulation — in vitiligo, UVB activates melanocyte stem cells in hair follicle reservoirs, triggering migration and repigmentation of depigmented patches
• Vitamin D3 induction — UVB stimulates vitamin D synthesis in the skin, which itself has immunomodulatory effects that may contribute to therapeutic benefit

Conditions Treated

Plaque Psoriasis

Narrowband UVB is a first-line treatment for moderate-to-severe plaque psoriasis and is recommended by major dermatology guidelines worldwide. Clinical studies demonstrate meaningful improvement in approximately 75–80% of patients completing a full initial course, with many achieving near-complete or complete clearance. It is particularly valuable for patients with extensive body surface area involvement where topical treatment alone is impractical.

Atopic Dermatitis (Eczema)

For patients with moderate-to-severe or widespread atopic dermatitis who have not responded to topical steroids and calcineurin inhibitors, narrowband UVB is highly effective. It reduces inflammation, pruritus (itch), and the overall eczema severity score, often allowing patients to reduce or discontinue systemic medications.

Vitiligo

Narrowband UVB is the most effective non-surgical treatment for generalized vitiligo. By stimulating melanocyte stem cells in the follicular reservoir, it triggers repigmentation — visible initially as perifollicular pigmented spots that gradually expand and coalesce. Response rates of 50–70% significant repigmentation are reported, with the best results on the face and trunk. Treatment typically requires longer courses than psoriasis — often 6–12 months or more.

Prurigo Nodularis

This condition — characterized by intensely itchy, thickened nodules — is notoriously difficult to treat. Phototherapy is one of the most effective interventions, reducing both the itch and the nodular lesions by interrupting the itch-scratch cycle and suppressing the local neuroinflammatory response.

Mycosis Fungoides (Cutaneous T-Cell Lymphoma)

Narrowband UVB is an established treatment for early-stage (patch and plaque stage) mycosis fungoides, directly targeting the malignant T-cells in the skin. It is often used as monotherapy in early disease or as part of a combination approach in more advanced cases, under the joint management of dermatology and oncology.

What to Expect at Your Sessions

Phototherapy sessions at Dermatology of Seattle are brief and straightforward:

• You undress to expose the treatment area (or fully for full-body treatment) and step into the phototherapy booth
• Protective goggles are provided — UV eye protection is required at every session
• Male patients use a genital shield to minimize cumulative UV exposure to the sensitive genital skin
• You stand with arms slightly away from your body for even light distribution
• The session lasts seconds to a few minutes — starting very short (often 10-30 seconds at the first session) and incrementally increasing each visit
• The light turns off automatically; you step out, dress, and you are done
• There is no sensation during treatment beyond mild warmth; a slight pink flush after the session is expected and normal

If you develop significant redness, blistering, or burning after a session — signs of overexposure — contact our office before your next appointment so your dose can be adjusted.

Narrowband UVB vs. PUVA: Key Advantages

PUVA (psoralen + UVA) was the dominant phototherapy for decades, but narrowband UVB has largely replaced it as the first-choice treatment. Here is why:

Safety Considerations

Narrowband UVB has an excellent safety record. The most common side effects are mild and expected:

• Mild erythema (pinkness) — normal and expected; indicates the dose is working
• Dryness and tightness — managed with regular moisturization
• Occasional itching in the first few sessions — typically resolves as treatment continues

The theoretical long-term skin cancer risk associated with cumulative UV exposure is a valid concern, but clinical evidence for narrowband UVB specifically shows this risk to be very low — far lower than PUVA and comparable to ordinary sun exposure from outdoor activities. To further minimize risk, we recommend:

• Annual full-body skin examinations throughout and after a course of phototherapy
• Consistent sunscreen use on sun-exposed areas on treatment days
• Reporting any new, changing, or unusual skin lesions promptly